2 Growth Stocks to Buy Hand Over Fist in February
Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in other industries -- even in healthcare, a sector some investors might consider boring. Two healthcare stocks that may or may not be boring, but that regardless look like strong growth stocks to invest in this month, are Eli Lilly (NYSE: LLY) and Sarepta Therapeutics (NASDAQ: SRPT).Eli Lilly has been a terrific stock to own for the past five years, thanks to its excellent clinical and regulatory progress. The company's breakthroughs are paying off. In each of the past six quarters, Eli Lilly's revenues have increased by more than 20% year over year, which is an incredible result for a pharmaceutical giant.LLY Operating Revenue (Quarterly YoY Growth) data by YCharts.Continue reading
Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in other industries -- even in healthcare, a sector some investors might consider boring. Two healthcare stocks that may or may not be boring, but that regardless look like strong growth stocks to invest in this month, are Eli Lilly (NYSE: LLY) and Sarepta Therapeutics (NASDAQ: SRPT).
Eli Lilly has been a terrific stock to own for the past five years, thanks to its excellent clinical and regulatory progress. The company's breakthroughs are paying off. In each of the past six quarters, Eli Lilly's revenues have increased by more than 20% year over year, which is an incredible result for a pharmaceutical giant.
LLY Operating Revenue (Quarterly YoY Growth) data by YCharts.
